Laura DeMaster PhD U.S. FDA

Laura DeMaster is a Biological Reviewer in CBER, Office of Therapeutic Products (OTP), Office of Gene Therapy (OGT), Gene Therapy Branch 4 (GTB4). GTB4 reviews cell-based gene therapy submissions across all phases of the product life cycle.